...
首页> 外文期刊>Cancer immunology, immunotherapy : >Aminoacyl-tRNA synthetase-interacting multifunctional protein 1 suppresses tumor growth in breast cancer-bearing mice by negatively regulating myeloid-derived suppressor cell functions
【24h】

Aminoacyl-tRNA synthetase-interacting multifunctional protein 1 suppresses tumor growth in breast cancer-bearing mice by negatively regulating myeloid-derived suppressor cell functions

机译:氨基酰基-tRNA合成酶相互作用的多功能蛋白1通过负调控髓样来源的抑制细胞功能来抑制荷瘤小鼠的肿瘤生长

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Myeloid-derived suppressor cells (MDSCs) are one of the most important cell types that contribute to negative regulation of immune responses in the tumor microenvironment. Recently, aminoacyl-tRNA synthetase-interacting multifunctional protein 1 (AIMP1), a novel pleiotropic cytokine, was identified as an antitumor protein that inhibits angiogenesis and induces antitumor responses. However, the effect of AIMP1 on MDSCs in the tumor environment remains unclear. In the present study, we demonstrated that AIMP1 significantly inhibited tumor growth in 4T1 breast cancer-bearing mice and reduced MDSCs population of tumor sites and spleens of tumor-bearing mice. AIMP1 reduced expansion of MDSCs from bone marrow-derived cells in the tumor-conditioned media. AIMP1 also negatively regulated suppressive activities of MDSCs by inhibiting IL-6 and NO production, and Arg-1 expression. Furthermore, treatment of breast cancer-bearing mice with AIMP1 decreased the capacity of MDSCs to suppress T cell proliferation and Treg cell induction. Western blot and inhibition experiments showed that downregulation of MDSCs functions by AIMP1 may result from attenuated activation of STATs, Akt, and ERK. These findings indicate that AIMP1 plays an essential role in negative regulation of suppressive functions of MDSCs. Therefore, it has a significant potential as a therapeutic agent for cancer treatment.
机译:骨髓来源的抑制细胞(MDSC)是最重要的细胞类型之一,在肿瘤微环境中有助于负调节免疫反应。最近,一种新型多效性细胞因子,与氨酰-tRNA合成酶相互作用的多功能蛋白1(AIMP1)被确定为一种抑制肿瘤血管生成并诱导抗肿瘤反应的抗肿瘤蛋白。然而,AIMP1在肿瘤环境中对MDSCs的作用仍不清楚。在本研究中,我们证明了AIMP1可以显着抑制4T1荷瘤小鼠的肿瘤生长,并减少荷瘤小鼠脾脏的MDSCs群体。 AIMP1减少了肿瘤条件培养基中来自骨髓细胞的MDSC的扩增。 AIMP1还通过抑制IL-6和NO产生以及Arg-1表达来负调节MDSC的抑制活性。此外,用AIMP1处理荷瘤小鼠会降低MDSC抑制T细胞增殖和Treg细胞诱导的能力。 Western印迹和抑制实验表明,AIMP1对MDSCs功能的下调可能是由于STATs,Akt和ERK的激活减弱所致。这些发现表明AIMP1在MDSCs抑制功能的负调节中起重要作用。因此,其作为癌症治疗剂具有巨大的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号